SCHEMBL7022015

SCHEMBL7022015

COC(=O)Nc1cccc(C(CCNCc2ccccc2)c2cccc(NC(=O)OC)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 9/20 0.53
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
PPARG P37231 1/20 0.47
GPR55 Q9Y2T6 2/20 0.45
TP53 P04637 1/20 0.45
HTR1A P08908 1/20 0.45
CNR1 P21554 1/20 0.45
HTR7 P34969 1/20 0.45
HTR6 P50406 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 2/20 0.45
MITF O75030 1/20 0.45
ALPL P05186 1/20 0.45
MAPT P10636 1/20 0.45
ALOX12 P18054 1/20 0.45
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321985 0.86 MEN1 (0.56) CASRMEN1KMT2AGPR55TP53
Hydrochloric Acid SCHEMBL7027322 0.85 MEN1 (0.55) CASRMEN1KMT2AGPR55TP53
SCHEMBL7027312 0.79 MEN1 (0.65) CASRMEN1KMT2A
SCHEMBL7028479 0.76 RXFP1 (0.42) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL7595294 0.75 CASR (0.50) CASRMEN1KMT2AHTR1AALDH1A1
SCHEMBL9392596 0.74 DRD2 (0.55) MEN1KMT2ALMNAMITFBCHE
SCHEMBL9392622 0.74 PPARA (0.50) MEN1KMT2APPARGSMN1; SMN2ALDH1A1
SCHEMBL3641265 0.73 KCNH2 (0.69) MEN1KMT2AHTR1ACNR1MITF
SCHEMBL2092346 0.73 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1LMNAMAPTNPSR1
SCHEMBL7611177 0.73 RAB9A (0.55) MEN1KMT2ASMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030032834-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-13 US disclosed
EP-1257528-A1 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-20 EP disclosed
WO-2001060786-A1 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032834-A1 Aminoalcohol derivatives ADRB1, ADRB2, ADRB3 CASR 1433/4885MEN1 4166/4885KMT2A 3486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.